Physician
Rume Medical Group, INC.
Rume Medical Group, INC. was paid $767K by Medicaid between Sep 2021 and Oct 2024, across 19 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 24% of everything it billed.
33Billing provider infoRUME MEDICAL GROUP, INC.
IRVINE, CA 92612
IRVINE, CA 92612
33aNPI1154994556assigned 07/22/2021
33bProvider typeAddiction Medicine (Psychiatry & Neurology) Physician
28Total paid$767K
24GClaims50,251
24DCodes billed19
24AFirst – last monthSep 2021 – Oct 2024
Compared with peers
Next to other Addiction Medicine (Psychiatry & Neurology) Physician providers in California
Rank by total paid#1 of 5
Median peer was paid$1K
This provider vs. median758×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 3,926 | $22K | |
| 2022 | 35,754 | $564K | |
| 2023 | 10,085 | $176K | |
| 2024incomplete | 486 | $5K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 24% | 6,733 | 5,341 | $182K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 22% | 25,637 | 19,478 | $168K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 19% | 3,007 | 2,126 | $147K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 9.1% | 2,190 | 2,151 | $70K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 6.8% | 5,752 | 3,373 | $52K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 5.0% | 2,030 | 1,985 | $38K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.9% | 604 | 448 | $38K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.9% | 1,073 | 928 | $14K |
| 87428 | 1.8% | 715 | 463 | $14K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.5% | 108 | 104 | $12K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.2% | 1,106 | 778 | $9K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 268 | 230 | $6K |
7 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 274 | $5K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 272 | $5K |
| 99441 | <1% | 181 | $3K | |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | <1% | 185 | $3K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 14 | $454.91 |
| 0004A | <1% | 43 | $199.60 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 59 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAMMIRO, ASHLY (DIRECTOR REVENUE CYCLE MGMT.)